Skip to Content

Join the 'Metformin' group to help and get support from people like you.

Metformin News

Diabetes Drug May Not Help Obese Women Have Normal-Weight Babies

Posted 6 days ago by Drugs.com

WEDNESDAY, Feb. 3, 2016 – Giving the diabetes drug metformin to obese pregnant women may not help their newborns come into the world at a healthier weight, a new trial finds. The study, reported Feb. 4 in the New England Journal of Medicine, adds to evidence that metformin does not curb obese women's risk of having an abnormally large newborn. On the other hand, the British researchers found the drug did help control a woman's own weight gain during pregnancy. And it may slash the risk of a potentially dangerous complication called preeclampsia. "Those findings bring to light some potential benefits of metformin for these women," said Dr. Jerrie Refuerzo, an associate professor of obstetrics and gynecology at the University of Texas Health McGovern Medical School, in Houston. For now, diet and exercise will remain the mainstay of managing obesity during pregnancy, according to ... Read more

Related support groups: Obesity, Diabetes, Type 2, Metformin, Weight Loss, Glucophage, Janumet, Delivery, Glucophage XR, Vitamin/Mineral Supplementation during Pregnancy/Lactation, ActoPlus Met, Glumetza, Glyburide/Metformin, Avandamet, Jentadueto, Glucovance, Janumet XR, Gestational Diabetes, Glipizide/Metformin, Metformin/Pioglitazone, Kombiglyze XR

Diabetes Drug Improves Gut Bacteria, Study Finds

Posted 4 Dec 2015 by Drugs.com

FRIDAY, Dec. 4, 2015 – The diabetes drug metformin appears to trigger favorable changes in intestinal bacteria, a new study finds. Researchers analyzed the intestinal bacteria populations in 784 people with and without type 2 diabetes who lived in China, Denmark and Sweden. The results showed that taking metformin had positive effects on the intestinal bacteria of people with type 2 diabetes. Specifically, the drug improved the ability of the bacteria to produce certain types of short-chain fatty acids that reduce blood sugar levels in different ways. The researchers also found that patients who take metformin have more coliform bacteria in their intestines, which may explain why the drug causes side effects such as bloating and increased flatulence. "We weren't able to show that other types of antidiabetic drugs had any actual impact on the gut microbiota. When studying type 2 ... Read more

Related support groups: Diabetes, Type 2, Metformin, Irritable Bowel Syndrome, Glucophage, Janumet, Insulin Resistance, Acidophilus, Glucophage XR, Florastor, ActoPlus Met, Glumetza, Glyburide/Metformin, Avandamet, Jentadueto, Glucovance, Janumet XR, Metformin/Pioglitazone, Glipizide/Metformin, Flora-Q, Floranex

Metformin May Not Help Obese Teens With Type 1 Diabetes

Posted 2 Dec 2015 by Drugs.com

TUESDAY, Dec. 1, 2015 – Metformin is the standby drug for millions of people with type 2 diabetes, but a new study finds that adding it to insulin therapy won't boost blood sugar control for overweight teens with type 1 diabetes. In type 1 diabetes, which comprises about 5 percent of diabetes cases, the body is unable to produce the insulin it needs. So, supplemental insulin is a must for people with the disease. The new study was led by Kellee Miller of the Jaeb Center for Health Research in Tampa, Fla. As her team explained, young people with type 1 diabetes are at even higher metabolic risk if they become overweight or obese, especially in adolescence. That's because both obesity and puberty may cause the patient to require higher levels of supplemental insulin, complicating blood sugar control, the researchers said. Metformin – a pill taken to help lower blood sugar – is widely ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Diabetes, Type 1, Glucophage, Diabetic Neuropathy, Janumet, Diabetic Nerve Damage, Pre-Diabetes, Diabetes Mellitus, Glucophage XR, ActoPlus Met, Glumetza, Glyburide/Metformin, Avandamet, Jentadueto, Glucovance, Janumet XR, Glipizide/Metformin, Metformin/Pioglitazone

New Diabetes Cases Among Americans Drop for First Time in Decades: CDC

Posted 1 Dec 2015 by Drugs.com

TUESDAY, Dec. 1, 2015 – In a sign that Americans may finally be turning the corner in the fight against diabetes – and possibly obesity – federal health statistics released Tuesday show that the number of new cases of diabetes has dropped for the first time in decades. The decline wasn't sudden or dramatic. But, the number of new diabetes cases went from 1.7 million in 2009 to 1.4 million in 2014, according to the U.S. Centers for Disease Control and Prevention. "It seems pretty clear that incidence rates have now actually started to drop. Initially it was a little surprising because I had become so used to seeing increases everywhere we looked," CDC researcher Edward Gregg told The New York Times. The proportion of Americans with diabetes is still twice what it was in the early 1990s. And not every racial group has made strides against the blood sugar disease, which is often ... Read more

Related support groups: Obesity, Diabetes, Type 2, Metformin, Insulin, Victoza, Weight Loss, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Janumet, Bydureon, Byetta, Glyburide, Lantus Solostar, Actos, Levemir, Invokana

Too Many Seniors With Diabetes Are Overtreated, Study Suggests

Posted 29 Oct 2015 by Drugs.com

THURSDAY, Oct. 29, 2015 – When it comes to treating seniors with diabetes, new research suggests that doctors often don't cut back on medications, even when treatment goals are surpassed. The study found that when people had potentially dangerous low blood sugar levels, just 27 percent had their medicines decreased. And when blood pressure treatments lowered blood pressure levels too much, just 19 percent saw a reduction in their medications. "As people get older, the risks of overtreating become greater, and the benefits become shorter. We have to start emphasizing that more isn't always better," said study author Dr. Jeremy Sussman, an assistant professor of internal medicine at the University of Michigan in Ann Arbor and a primary care doctor at the Ann Arbor VA System. The findings were published online Oct. 26 in the journal JAMA Internal Medicine. Practice guidelines generally ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Janumet, Bydureon, Byetta, Glyburide, Lantus Solostar, Actos, Levemir, Invokana, Glimepiride, Novolin R

Tight Control of Type 2 Diabetes May Help Prevent Dementia

Posted 15 Sep 2015 by Drugs.com

TUESDAY, Sept. 15, 2015 – Keeping blood sugar levels in check may have a protective effect against dementia in people who have type 2 diabetes, new Swedish research suggests. "The positive association between [average blood sugar levels] and risk of dementia in fairly young patients with type 2 diabetes indicates a potential for prevention of dementia with improved blood sugar control," study author Dr. Aidin Rawshani, from the National Diabetes Register and Institute of Medicine in Gothenburg, Sweden, and colleagues wrote. However, the study wasn't able to definitively prove a cause-and-effect relationship between blood sugar levels and dementia; it was only able to show an association between these factors. The study included almost 350,000 people with type 2 diabetes. They were all registered in the Swedish National Diabetes Registry between January 2004 and December 2012. They had ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Dementia, Glucophage, Novolog, Glipizide, Alzheimer's Disease, Humalog, Janumet, Glyburide, Lantus Solostar, Actos, Levemir, Invokana, Glimepiride, Novolin R, Amaryl, Pioglitazone

FDA Warns of Joint Pain Tied to Common Type 2 Diabetes Drugs

Posted 31 Aug 2015 by Drugs.com

FRIDAY, Aug. 28, 2015 – Use of a class of widely prescribed medications for type 2 diabetes is tied to severe joint pain in some patients, the U.S. Food and Drug Administration warned on Friday. The drugs – sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta) and alogliptin (Nesina) – come from a newer class of medications called DPP-4 inhibitors. The drugs can be taken alone or used in conjunction with other diabetes drugs, such as metformin. DPP-4 inhibitors help fight type 2 diabetes by boosting the amount of insulin the body produces after each meal, when blood sugar levels are typically high. However, in a statement, the FDA said the medications "may cause joint pain that can be severe and disabling," and the agency "has added a new Warning and Precaution about this risk to the labels of all medicines in this drug class." The FDA stressed that patients who take ... Read more

Related support groups: Diabetes, Type 2, Metformin, Januvia, Glucophage, Janumet, Pre-Diabetes, Onglyza, Diabetes Mellitus, Glucophage XR, Tradjenta, ActoPlus Met, Sitagliptin, Glumetza, Glyburide/Metformin, Jentadueto, Avandamet, Janumet XR, Glucovance, Metformin/Pioglitazone, Linagliptin

Health Tip: Diabetes Can Take a Toll on Teeth and Mouth

Posted 10 Aug 2015 by Drugs.com

-- Diabetes, especially when uncontrolled, can cause damage to your mouth and teeth. The Mouthhealthy.org website says possible effects of diabetes on the teeth and mouth include: Dry mouth, due to decreased saliva production. Increased risk of cavities due to less saliva. Gingivitis, characterized by bleeding, inflamed gums. Difficulty tasting food. Slower healing of mouth wounds. Increased risk of infection. Among diabetic children. teeth emerging earlier than expected. Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Oral and Dental Conditions, Xerostomia, Victoza, Lantus, Diabetes, Type 1, Januvia, Glucophage, Novolog, Toothache, Glipizide, Burning Mouth Syndrome, Humalog, Diabetic Neuropathy, Janumet, Bydureon, Byetta, Insulin Resistance

People With Type 2 Diabetes Do Benefit From Blood Sugar Checks

Posted 5 Aug 2015 by Drugs.com

WEDNESDAY, Aug. 5, 2015 – Personalized blood sugar self-monitoring benefits people with type 2 diabetes even if they're not taking insulin, a new small study shows. Some experts have questioned the value of self-monitoring in this group, and many insurers – including Medicare – limit the reimbursement of blood sugar (glucose) testing strips to one a day for people with type 2 diabetes. This study included 11 people with type 2 diabetes who worked with the researchers to create personalized, structured self-monitoring blood glucose schedules. In most cases, self-monitoring twice a day was the most helpful in providing meaningful information about blood sugar levels. However, there was room for individualization based on a patient's type of lifestyle and needs. For example, a patient might check their blood sugar twice a day three days a week instead of once a day seven days a week, ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Victoza, Lantus, Januvia, Glucophage, Novolog, Glipizide, Humalog, Janumet, Bydureon, Byetta, Glyburide, Lantus Solostar, Actos, Levemir, Invokana, Pre-Diabetes, Glimepiride

Diabetes Drug Given to Obese Moms-to-Be Won't Keep Baby's Weight Down

Posted 10 Jul 2015 by Drugs.com

FRIDAY, July 10, 2015 – Taking the diabetes drug metformin during pregnancy doesn't reduce an obese woman's risk of having an overweight baby, a new study finds. Exposure to excess blood sugar in the womb may contribute to a baby having a high birth weight. So, British researchers looked at whether giving metformin – a drug that helps regulate blood sugar – to obese women during pregnancy would reduce the weight of their babies. Heavier babies are more likely to be overweight in adulthood and also have a higher risk of diabetes, heart disease and other illnesses later in life, the researchers said. In the study, 226 women received the drug from the second trimester until their babies were born, while 223 women took a placebo. There was no difference in the weight of babies born to mothers in the two groups. Taking metformin did lower women's blood sugar and levels of other markers ... Read more

Related support groups: Obesity, Metformin, Glucophage, Glucophage XR, Glumetza, Gestational Diabetes, Fortamet, Riomet

Tight Blood Sugar Control Helps the Heart in Type 2 Diabetes

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Strictly controlling blood sugar levels appears to keep people with type 2 diabetes from developing heart problems, a new study finds. Tight control of blood sugar reduces the odds of heart attack, stroke, heart failure or amputation by about 17 percent, according to the study. But controlling blood sugar alone won't prevent deaths from heart disease or other causes. For that, lowering blood pressure and cholesterol are also needed, the researchers suggested. "In addition to regular exercise, a good diet and not smoking, people with diabetes can dramatically reduce their risk of strokes and heart attacks by taking a statin, keeping their blood pressure under control and getting their average blood sugar at least to moderate control with an A1C of about 8," said lead researcher Dr. Rodney Hayward. He is a senior research scientist at the VA Center for Clinical ... Read more

Related support groups: Diabetes, Type 2, Metformin, Insulin, Lantus, Glucophage, Novolog, Glipizide, Humalog, Janumet, Glyburide, Lantus Solostar, Levemir, Glimepiride, Novolin R, Amaryl, Novolin N, Humulin N, Ischemic Stroke - Prophylaxis, Glucophage XR, Humulin R

Diabetes Drug Metformin May Lower Glaucoma Risk

Posted 28 May 2015 by Drugs.com

THURSDAY, May 28, 2015 – The diabetes drug metformin was linked to a lower risk of developing the eye condition glaucoma in a new study. People who took the most metformin during the 10-year study period had a 25 percent reduced risk of glaucoma compared with people not taking the drug, researchers found. "Glaucoma is a leading cause of blindness worldwide and classic open-angle glaucoma develops in late middle age or late age. So we hypothesized that a drug that mimics caloric restriction, such as metformin, might reduce the risk of glaucoma," said lead researcher Julia Richards, a professor of ophthalmology and visual sciences at the University of Michigan in Ann Arbor. Exactly how metformin might reduce the risk of glaucoma isn't known, the researchers said. And, while this study found an association between metformin use and lower glaucoma risk, it wasn't designed to prove a ... Read more

Related support groups: Metformin, Glaucoma, Glucophage, Janumet, Glucophage XR, ActoPlus Met, Glumetza, Glyburide/Metformin, Avandamet, Glaucoma/Intraocular Hypertension, Jentadueto, Janumet XR, Glucovance, Metformin/Pioglitazone, Glipizide/Metformin, Riomet, Fortamet, Kombiglyze XR, Metformin/Sitagliptin, Invokamet

Diabetes Drug Metformin Safe for Patients With Kidney Disease: Review

Posted 23 Dec 2014 by Drugs.com

TUESDAY, Dec. 23, 2014 – Although metformin, the popular type 2 diabetes medication, is usually not prescribed for people with kidney disease, a new analysis shows the drug may be safer for these patients than once thought. Metformin has been used in the United States for two decades to help lower blood sugar levels among people with type 2 diabetes. The U.S. Food and Drug Administration cautions that people with kidney disease should not take the drug because it could increase their risk for a potentially serious condition called lactic acidosis. This is when lactic acid builds up in the bloodstream after oxygen levels in the body are depleted. After reviewing published research to evaluate the risks associated with metformin among people with mild to moderate kidney disease, a team of researchers led by Dr. Silvio Inzucchi, a professor of medicine at Yale University, found these ... Read more

Related support groups: Metformin, Glucophage, Chronic Kidney Disease, Glucophage XR, Glumetza, Fortamet, Riomet

FDA Approves Xigduo XR (dapagliflozin and metformin hydrochloride) for Type 2 Diabetes

Posted 30 Oct 2014 by Drugs.com

WILMINGTON, Del., October 30, 2014 – AstraZeneca today announced that the U.S. Food and Drug Administration has approved once-daily Xigduo XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes. Xigduo XR combines two anti-hyperglycemic agents with complementary mechanisms of action, dapagliflozin (trade name in the U.S. Farxiga™), an inhibitor of sodium-glucose cotransporter 2 (SGLT2), and metformin hydrochloride extended-release, a biguanide, in a once-daily oral tablet. SGLT2 inhibitors are a relatively new class of medicines that remove glucose from the body via the kidneys. Xigduo XR is the first and only once-daily combination tablet of an SGLT2 inhibitor and metformin hydrochloride extended-release to be approved in the United States. Xigduo XR is indicated as an adjunct therapy to diet and exercise to improve glycemic c ... Read more

Related support groups: Diabetes, Type 2, Metformin, Farxiga, Dapagliflozin

Metformin Beats Other Type 2 Diabetes Drugs for First Treatment: Study

Posted 28 Oct 2014 by Drugs.com

TUESDAY, Oct. 28, 2014 – People newly diagnosed with type 2 diabetes who are initially given the drug metformin are less likely to eventually need other drugs to control their blood sugar, a new study suggests. The study found that, of those started on metformin, only about one-quarter needed another drug to control their blood sugar. However, people who were started on type 2 diabetes drugs other than metformin often needed a second drug or insulin to control their blood sugar levels, the researchers said. "This study supports the predominant practice, which is that most people are started on metformin," said lead researcher Dr. Niteesh Choudhry, an associate professor of medicine at Harvard Medical School in Boston. "Metformin might be more effective than others in controlling blood sugar," he noted. "Metformin, which is one of the oldest drugs we have and which the guidelines ... Read more

Related support groups: Diabetes, Type 2, Metformin, Glucophage, Glucophage XR, Glumetza, Fortamet, Riomet

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Diabetes, Type 2, Polycystic Ovary Syndrome, Insulin Resistance, Female Infertility

Related Drug Support Groups

Glucophage, Glucophage XR, Glumetza, Riomet, Fortamet

Metformin Patient Information at Drugs.com